Premium
Eli Lilly And Co (0Q1G)
LSE
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Eli Lilly & Co on Tuesday said it expects to report lower fourth quarter revenue than the bottom of a range it had pr ...
Popular diabetes and obesity drugs by Novo Nordisk AS and Eli Lilly & Co could also help to protect the kidneys, a ne ...
Eli Lilly & Co on Wednesday reported strong revenue growth in the third quarter and a return to profit, as it develop ...
Eli Lilly & Co on Monday announced it has appointed Lucas Montarce as chief financial officer with immediate effect. ...
Eli Lilly & Co on Thursday raised annual guidance once again, as it reported double-digit growth in the second quarte ...
Patients taking Eli Lilly & Co's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nord ...
Alphabet Inc on Wednesday said Anat Ashkenazi will become the company's new chief financial officer from the end of J ...
Eli Lilly & Co announced on Wednesday that it has come to an agreement with Totality Medispa over the latter's claim ...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 81.83 | 81.83 | 81.83 | 521 | 81.83 | DE |
| 4 | 0 | 0 | 81.83 | 81.83 | 81.83 | 551 | 81.83 | DE |
| 12 | 0 | 0 | 81.83 | 81.83 | 81.83 | 749 | 81.83 | DE |
| 26 | 0 | 0 | 81.83 | 81.83 | 81.83 | 842 | 81.83 | DE |
| 52 | 0 | 0 | 81.83 | 81.83 | 81.83 | 720 | 81.83 | DE |
| 156 | 0 | 0 | 81.83 | 81.83 | 81.83 | 319 | 81.83 | DE |
| 260 | 0 | 0 | 81.83 | 81.83 | 81.83 | 227 | 81.83 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
